Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Aug 15;16(8):3481–3495. doi: 10.4251/wjgo.v16.i8.3481

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

PMC Copyright notice

Comparing the survival of camrelizumab plus apatinib and hepatic artery infusion chemotherapy alone and camrelizumab plus apatinib and hepatic artery infusion chemotherapy combined with microwave ablation treatment for patients with advanced hepatocellular carcinoma. A-D: Kaplan-Meier curves for the overall survival (OS) (A), progression-free survival (PFS) (B), intrahepatic PFS (IPFS) (C) and extrahepatic PFS (EPFS) (D) of patients with advanced hepatocellular carcinoma before propensity score matching (PSM); E-H: Kaplan-Meier curves for the OS (E), PFS (F), IPFS (G) and RPFS (H) of patients with advanced hepatocellular carcinoma after PSM. T-M: Camrelizumab plus apatinib and hepatic artery infusion chemotherapy combined with MWA; T-A: Camrelizumab plus apatinib and hepatic artery infusion chemotherapy alone; OS: Overall survival; PFS: Progression-free survival; IPFS: Intrahepatic progression-free survival; EPFS: Extrahepatic progression-free survival; HR: Hazard ratio; CI: Confidence interval.